Target intelligence / Profile preview

Mycobacterium tuberculosis antigen Rv3620

Molecular classification: Antigen, Protein

Overview

Rv3620 is a protein antigen from Mycobacterium tuberculosis (Mtb), the bacterium responsible for tuberculosis. It has been identified as an immunogenic component and is used in research and vaccine development targeting Mtb infection. It has been shown to induce partial protection against Mtb in preclinical models, making it a candidate for inclusion in subunit vaccines. The antigen is included in the ID93 fusion protein, which combines four Mtb antigens (Rv3619, Rv1813, Rv3620, and Rv2608) to enhance immunogenicity and protective efficacy.

Other names: Rv3620

Biological functions

Immune responseAntigen presentation

Disease associations

InfectionTuberculosis

Beyond the preview

Go deeper on Mycobacterium tuberculosis antigen Rv3620.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis antigen Rv3620.

Explore the full profile